|
|
Saturday Presenters
 |
Lawrence Dagrosa, MD Urological Oncologist
Dr. Dagrosa has served as a Urological Oncologist with Dartmouth Health since 2017. He is also Assistant Professor of Surgery at Geisel School of Medicine, and was named a Top Doctor by New Hampshire Magazine in 2023 & 2024. Previously, Dr. Dagrosa completed his fellowship in Urological Oncology at the Medical University of South Carolina and his residency in Urology at Dartmouth Hitchcock Medical Center. |
|---|---|
 |
Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP Clinical Professor/Oncology Pharmacist Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 25 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is a Clinical Professor at the UConn School of Pharmacy and at the UConn School of Medicine. Her practice site is at the UConn Health Carole and Ray Neag Comprehensive Cancer Center, where she works in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers, and was a co-lead in the developing of their oral anticancer medication program. Dr. Holle is a Past President of the Hematology Oncology Pharmacy Association (HOPA) and a past Secretariat member and past Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations. Dr. Holle’s clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, cannabis, and oral anticancer therapy management. She has authored numerous articles and chapters on oncology and teaching-related topics. |
 |
Kathryn Kirkland, MD, FAAHPM Professor and Executive Vice Chair of Medicine (Palliative Medicine) Dartmouth-Hitchcock Kathryn Kirkland, MD, is a professor of medicine and of health policy and clinical practice and holds the Dorothy and John J. Byrne, Jr. Distinguished Chair in palliative medicine at the Geisel School of Medicine. She has served as section chief and director of palliative care at Dartmouth-Hitchcock Health and as Interim Chair of Medicine. She integrates narrative medicine teaching into medical student, resident, fellow, faculty and healthcare team education and helps facilitate cross-disciplinary activities with colleagues at Dartmouth College. Her interests include the role and mechanisms of narrative practices, such as close reading and creative writing, in preparing clinicians for the co-design and delivery of empathic, effective healthcare and in the facilitation of joy in work. Kathy grew up in Charleston, SC. As a southerner, she innately understands the power of story, and this has threaded through her career. After graduating as an English major from Mount Holyoke College and with a medical degree from Dartmouth Medical School, she completed her medical training at Columbia-Presbyterian, Duke University, and Dartmouth-Hitchcock Medical Centers. After two years with CDC’s Epidemic Intelligence Service, she devoted the first 20 years of her professional career to infectious diseases and healthcare epidemiology, both of which rely heavily on eliciting the stories of others. Her pivot to Palliative Medicine 10 years ago was driven by a desire to more effectively use the stories of patients and care partners in the co-construction of better experiences living with serious illness. Kathy is a Fellow of the American Academy of Hospice and Palliative Medicine, and a member of the International Society for the Study of Narrative. Outside of work, she is an avid fly fisher, cyclist, and fiction reader. |
 |
Richard Lee, MD Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers After completing a bachelor's and a master's degree at Harvard, Dr. Lee then completed his medical school (M.D.) and graduate school (Ph.D.) training at the Albert Einstein College of Medicine, in the Bronx, New York. He went to Massachusetts General Hospital for internal medicine residency training and then completed medical oncology fellowship training through the Dana-Farber Cancer Institute / Massachusetts General Hospital joint program. During that time, he performed basic science research at the Whitehead Institute of Massachusetts Institute of Technology. |
 | Nataniel Lester-Coll, MD Network Chair, Radiation Oncology Dr. Lester-Coll is a radiation oncologist at the University of Vermont Medical Center and associate professor at the Larner College of Medicine at UVM in Burlington, VT. Dr. Lester-Coll specializes in treating patients with prostate cancer, lung cancer, gastrointestinal cancer, sarcoma, lymphoma and metastatic malignancies. His research interests include clinical trials, health services research, comparative effectiveness research, large database research, cost-effectiveness analysis, and decision analysis. Dr. Lester-Coll is a strong believer in providing quality cancer care that is respectful of and responsive to individual patient preferences, needs, values, and ensuring that patient values guide all clinical decisions. He strives to ensure that information regarding cancer management is spelled out as clearly as possible to his patients to help them make informed decisions and navigate what can often be a challenging landscape. He works hard to be a patient advocate and make certain that care is followed through. Dr. Lester-Coll values the relationships he establishes with each of his patients, and believes that goes a long way in improving their health. |
 |
Hyman B. Muss MD Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Hyman B. Muss MD is an experienced clinician-scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine and the Cancer and Aging Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest is in education and research focused on cancer in older patients, and he is an internationally recognized leader in this area. His particular interest and research expertise is in the care of breast cancer patients with a focus on the management of older women. He also has a major interest in breast cancer survivorship and long-term toxicity of treatment. After working with his previous UNC colleague, Dr. Ned Sharpless, he is exploring the role of biomarkers of aging and their potential role as predictors of toxicity and survival. Dr. Muss has developed and been PI of multiple clinical and translational trials, including the lead author of an NCI-sponsored intergroup trial that compared standard care with oral chemotherapy in older women with early-stage breast cancer and which, for the first time, showed the value of chemotherapy in this older populations. He mentors medical students, medicine residents, junior faculty, and, more recently, Geriatric Oncology fellows. He previously co-chaired the Alliance Committee on Cancer in Older Adults. He has been co-chair of the Breast Committee for the CALGB, Chair and a member of the board of Directors of the American Board of Internal Medicine, and a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and the ASCO Foundation. He was awarded the B.J. Kennedy Award in Geriatric Oncology and the Allen Lichter Visionary Leader Award by ASCO, the Susan G. Komen for the Cure Brinker Award for Scientific Distinction in Clinical Research, and an honorary Doctor of Science Degree from his alma mater, Lafayette College. He served in the U.S. Army in Vietnam and was awarded the Bronze Star medal.
|
 |
Jens Rueter, MD Chief Medical Officer, Medical Director Dr. Rueter is the Chief Medical Officer at The Jackson Laboratory and the Medical Director for the MCGI and the Associate Director for Translational Education at the JAX Cancer Center. As a member of the JAX senior management team, he works with several JAX clinical genomics and education experts as well as several national leaders on advancing the field of Precision Medicine to individualize cancer treatments for individual patients and improve their outcomes. Previously, Dr. Rueter was a hematologist/oncologist at EMMC Cancer Care and the medical director for EMMC Biobank and translational research in Brewer, Maine. After graduating from medical school in Berlin, Germany, Rueter completed his residency in internal medicine at Tulane University and fellowship training in hematology/oncology at the University of Pennsylvania. |
.jpg) |
Christine Walko, PharmD Senior Member, Department of Pathology, Christine M. Walko graduated with her Pharm.D. degree from Duquesne University in Pittsburgh, Pennsylvania, and completed a pharmacy practice residency at the Medical College of Virginia/VCU in Richmond, Virginia, and a hematology/oncology specialty residency at the University of North Carolina (UNC). She stayed at UNC to complete a 2-year academic oncology fellowship focused on drug metabolism and translational research before taking an Assistant Professor position at UNC in the Division of Pharmacotherapy and Experimental Therapeutics until being recruited to Moffitt Cancer Center in January 2014 to assist with starting the institution’s first Precision Medicine Program. Dr. Walko is now a Senior Member in the Department of Pathology at Moffitt Cancer Center, Program Leader for Precision Medicine and an Attending on the Precision Medicine Clinical Service. She is also a Co-Chair for the ASCO TAPUR trial Molecular Tumor Board (MTB) and variant expert for the nationwide SWOG Precision Medicine trial focused on the clinical utility of Molecular Tumor Boards in Community Oncology Practices. Her research focus is on optimizing drug therapy using pharmacogenomics and pharmacokinetics to personalize intravenous and oral anticancer therapy for patients with cancer. |
Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org
This website brought to you by:
